WIN: WISE Cortical Strip for Intraoperative Neurophysiological Monitoring

Sponsor
Wise S.r.l. (Industry)
Overall Status
Completed
CT.gov ID
NCT03731455
Collaborator
Genae (Industry), Fondazione Don Carlo Gnocchi Onlus (Other)
32
5
1
9.4
6.4
0.7

Study Details

Study Description

Brief Summary

The WIN Study is a prospective, interventional, multi-center, open-label premarket study designed to confirm the safety, performance and intended use of the WISE Cortical Strip (WCS) for CE certification purposes. Participants with documented diagnosis of epilepsy or brain tumor requiring intracranial surgery, who meet all eligibility criteria, will undergo IntraOperative Neurophysiological Monitoring (IONM) during a neurosurgical intervention with the WCS and a comparator device.

Condition or Disease Intervention/Treatment Phase
  • Device: WISE Cortical Strip
N/A

Detailed Description

The IONM is the use of electrophysiological methods to identify important neural structures in the operative field, including eloquent areas, in order to monitor their functional integrity during the neurosurgical lesion resection. The benefit of performing functional monitoring of the areas surrounding the lesion is to minimize neurological damages during surgical lesions resection and thus to avoid and/or limit significant post-operative impairments. During the therapeutic resection of brain tumors or epileptogenic lesions, the use of the IONM is associated to other intraoperative techniques (e.g. brain mapping techniques) that, together to combined efforts of a multidisciplinary team of neurosurgeons, neuroradiologists, neuropsychologists, and neurophysiologists, contribute to the definition of location, extension, and extent of functional involvement that a lesion causes in an individual participant.

The principal electrophysiological methods to perform the IONM are the recording of brain's electrical activities (Somatosensory Evoked Potentials, SEPs and ElectroCorticoGraphy, ECoG) and electrical stimulation of motor regions (to elicit Motor Evoked Potentials, MEPs) using cortical strips placed on surface of the brain.

Thus, the WCS is intended to be used intraoperatively on the brain surface, to perform brain monitoring.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The neurosurgical intervention will be performed with both devices: investigational (Wise Cortical Strip, WCS) and comparator device.The neurosurgical intervention will be performed with both devices: investigational (Wise Cortical Strip, WCS) and comparator device.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Prospective, Interventional, Multi-center, Open-label, Premarket Study to Evaluate Safety, Performance and Usability of the Wise Cortical Strip for Intraoperative Neurophysiological Monitoring (WIN Study)
Actual Study Start Date :
Apr 9, 2019
Actual Primary Completion Date :
Jan 20, 2020
Actual Study Completion Date :
Jan 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational and Comparator devices

Investigational (WISE Cortical Strip, WCS) and comparator (Subdural Strip Electrode, Ad-Tech Medical Instruments Corporation) devices will be used together.

Device: WISE Cortical Strip
The WISE Cortical Strip is a medical device composed by a strip and by a cable.

Outcome Measures

Primary Outcome Measures

  1. Serious Adverse Device Effects (SADEs) of the WISE Cortical Strip. [For the entire duration of the surgeries and after 24 hours]

  2. The Signal-to-Noise Ratio percentage (SNR%) calculated on Somatosensory Evoked Potential (SEP) signals. [During the surgery]

Secondary Outcome Measures

  1. Impedance values measured for the WISE Cortical Strip. [During the surgery]

  2. Motor Evoked Potentials (MEPs). [During the surgery]

  3. Dedicated usability questionnaire. [Following surgeries]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Contacts and Locations

Locations

Site City State Country Postal Code
1 Klinikum der Universitat München Munich Germany 81377
2 Azienda Ospedaliera Universitaria Integrata Verona (AOUI Verona) Verona Italy 37126
3 Inselspital Bern Switzerland 3010
4 Luzerner Kantonsspital Luzern Switzerland 6000
5 Universitätsspital Zürich Switzerland 8091

Sponsors and Collaborators

  • Wise S.r.l.
  • Genae
  • Fondazione Don Carlo Gnocchi Onlus

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Wise S.r.l.
ClinicalTrials.gov Identifier:
NCT03731455
Other Study ID Numbers:
  • 001_WCS
First Posted:
Nov 6, 2018
Last Update Posted:
May 10, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wise S.r.l.

Study Results

No Results Posted as of May 10, 2021